Bio-Techne

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Bio-Techne and other ETFs, options, and stocks.

About TECH

Bio-Techne Corp. engages in the development, manufacture and sale of biotechnology reagents and instruments for the research and clinical diagnostic markets. It operates through the Protein Sciences, and Diagnostics and Genomics segments.

CEO

Kim Kelderman

CEOKim Kelderman

Employees

3,050

Employees3,050

Headquarters

Minneapolis, Minnesota

HeadquartersMinneapolis, Minnesota

Founded

1976

Founded1976

Employees

3,050

Employees3,050

TECH Key Statistics

Market cap

11.48B

Market cap11.48B

Price-Earnings ratio

45.58

Price-Earnings ratio45.58

Dividend yield

0.51%

Dividend yield0.51%

Average volume

1.09M

Average volume1.09M

High today

$76.67

High today$76.67

Low today

$68.00

Low today$68.00

Open price

$70.54

Open price$70.54

Volume

1.93M

Volume1.93M

52 Week high

$89.91

52 Week high$89.91

52 Week low

$51.79

52 Week low$51.79

TECH News

Simply Wall St 2h

Bio-Techne Corporation Shares Could Be 25% Above Their Intrinsic Value Estimate

Key Insights Using the 2 Stage Free Cash Flow to Equity, Bio-Techne fair value estimate is US$50.46 Bio-Techne is estimated to be 25% overvalued based on curr...

Reuters 7h

Bio-Techne beats third-quarter estimates on improving demand for biotech products

May 1(Reuters) - Bio-Techne on Wednesday beat third-quarter profit and revenue estimates, helped by better-than-expected demand for its cell and gene therapy pr...

TipRanks 22h

Bio-Techne Board Expansion and Strategic Director Appointments - TipRanks.com - TipRanks

The latest update is out from Bio-Techne (TECH). Bio-Techne Corporation has expanded its Board of Directors to eleven members and welcomed Dr. Judith Klimovsky...

Analyst ratings

86%

of 14 ratings

Buy

85.7%

Hold

14.3%

Sell

More TECH News

Simply Wall St 23h

These 4 Measures Indicate That Bio-Techne Is Using Debt Reasonably Well - Simply Wall St

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's balance sheet when you examine how risky...

TipRanks 2d

Bio-Techne announces new distribution agreement with Thermo Fisher

Bio-Techne (TECH) is pleased to announce a significant milestone in its commitment to providing cutting-edge solutions to its customers. Effective May 1, Bio-Te...

TipRanks 5d

Bio-Techne and Novomol-Dx announces development of Bio-Marker Pathfinder

Bio-Techne and Novomol-Dx, a molecular diagnostics company, announced the development of Bio-Marker Pathfinder, or BMP, a first of its kind ocular biomarker kit...